Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot Study

Iguratimod (IGU) can mitigate the symptoms of rheumatoid arthritis through its anti-inflammatory effects. The objective of this study was to investigate the clinical efficacy and safety of IGU in highly HLA-mismatched renal transplant recipients, in combination with standard immunosuppressive regime...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Jun, Sun, Li, Wang, Zijie, Chen, Hao, Han, Zhijian, Zhang, Hengcheng, Yang, Haiwei, Huang, Zhengkai, Fei, Shuang, Ju, Xiaobin, Tan, Ruoyun, Gu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650225/
https://www.ncbi.nlm.nih.gov/pubmed/34887851
http://dx.doi.org/10.3389/fimmu.2021.738392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650225/
https://www.ncbi.nlm.nih.gov/pubmed/34887851
http://dx.doi.org/10.3389/fimmu.2021.738392

Ejemplares similares